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Abstract 
 
Colon cancer is one of the most common death-caused cancer. The high mortality 
rate indicates that chemotherapy has not overcome cancer disease. Strategies and 
development of colon cancer treatment should be pursued. Compound 1-(2,5-
dihydroxyphenyl)-3-pyridine-2-yl-propenone is the 2ʹ,5ʹ-dihydroxychalcone derivative, of 
which the B ring was substituted with 2-pyridine ring. Chalcone and its derivatives have been 
reported to have several biological activities, such as cytotoxic, anti-inflammatory, antiHIV, 
and as a tyrosine kinase inhibitor. The objectives of this research was to determine the 
cytotoxic activity on WiDr colon cancer cells of 1-(2,5-dihydroxyphenyl)-3-pyridine-2-yl-
propenone. Cytotoxic activity was measured using MTT assay. Compound 1-(2,5-
dihydroxyphenyl)-3-pyridine-2-yl-propenone inhibited WiDr cell growth with the IC50 of  16 
µM. Morphology of WiDr cell showed that compound 1-(2,5-dihydroxyphenyl)-3-pyridine-2-
yl-propenone inhibited cell growth in dose dependent. 
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INTRODUCTION 
 
Cancer is the disease causing high 
number of mortality. In Indonesia, colon cancer 
become the most dangerous gastrointestinal 
disease after the hepotocelular cancer 
(Pusponegoro, 2004). Colon cancer could 
develop by the overexpression of 
cyclooxigenase 2 (COX-2) (Turíni and Dubois, 
2002). In the therapy of colon cancer, 5-
fluorouracil (5-FU) is used for the main 
therapy, but cannot give the satisfying result 
and just give effectivity in the therapy for 
approximately 20% of colon cancer patient 
(Arkenau, et al., 2005; Meyerhardt and  Mayer, 
2005). Therefore, the research for the invention 
and the development for new compound for 
colon canacer treatment is need to be done. 
One of the potential compound to 
develop as the cancer chemoprevention agent is 
the analog of calcon compound. Calcon is the 
compound having basic structure C6C3C6, where 
two aromatic rings (ring A and ring B) are 
connected with three atomic carbon. Calcon 
structures are generally found in flavonoid 
compounds. These compounds are found in 
fruits, vegetables, nuts, and tea (Patil, et al., 
2009). Calcon and its derivates are reported to 
have biological activities such as cytotoxicity, 
antimalaria, antileismania, antiinflamation, 
antiHIV, antifungi, and tyrosine kinase inhibitor 
(Saxena, et al., 2007).  
The modification of lacton compound 
with the change of fenyl ring on B position of 
4-cloro-2',4'-dihidroxycalcon and 2',5'-
dihydroxycalcon with 2-piridyl and their 
activity in anticancer have not been reported. 
Some of the modified compounds are 1-(2,4-
dihydroxyfenil)-3-piridin-2-il-propenon; 1-(2,5-
dihydroxyfenil)-(3-piridin-2-il)-propenon; 4-
cloro-2′,4′-dihydroxycalcon; and 2′,5′-
dihydroxycalcon. 
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The aim of this research is to test the 
cytotoxic potency of 1-(2,5-dihydroxyfenil)-(3-
piridin-2-il)-propenon in colon cancer cell 
WiDr. The synthesis of 1-(2,5-dihydroxyfenil)-
(3-piridin-2-il)-propenon has been succesfully 
done and showed the antiinflamation activity 
(Wibowo, 2013).  
The result of this study hopefully could 
be the basic theory in the development of 1-
(2,5-dihydroxyfenil)-(3-piridin-2-il)-propenon 
as the alternative of chemoprevention agent in 
colon cancer cell.Brazilein inhibits survivin 
protein and induces apoptosis in HepG2 
hepatocellular carcinoma cells (Zhong, et al., 
2009). This study was conducted to evaluate the 
cytotoxic effect of brazilein, both alone and in 
combination with doxorubicin on MCF-7/DOX 
cells by using MTT assay. 
 
MATERIALS AND METHODS 
 
Cell Culture 
Colon cancer cell WiDr is the collection 
of CCRC Faculty of Pharmacy UGM. WiDr 
cells were cultured in the RPMI (Gibco). The 
culture media contained 10% FBS (Ginco) and 
1% Penisilin Streptomicyn (Gibco). Cells were 
cultured in the temperature of 37C and 5% 
CO2. Cells are harvested with tripsin 0.25% 
(Gibco). 
 
Cytotoxic assay  
Exponentially The cytotoxic assay were 
done by MTT Assay. WiDr cells were 
distributed in 96-well plate as many as 10 x 10
3
 
cells/ well. Cells were incubated for 24 hours in 
CO2 incubator then were added with 100 µL of 
culture media containing sample in some 
concentration for 3 replication each 
concentration and then incubated again for 24 
hours. As the control are the DMSO solution, 
WiDr cell control, and culture media control 
(RPMI). In the end of the incubation time, the 
culture  media  were  removed  and cells  were  
washed with PBS. Then in each well were 
added by 100 µL MTT reagen and incubated 
for three hours in the temperature of 37C and 
5% CO2. After three hours, the solution of 10 % 
SDS in 0.1 N HCl were added as stopper 
reagen. Cells were incubated for a night in the 
room temperature and protected from the light, 
and the plate were shaked horizontally (with 
shaker) for 10 minutes, then were read with 
ELISA reader (BioRad) in λ 595 nm. 
 
RESULT AND DISCUSSION 
 
The cytotoxic assay give the potency 
evaluation of 1-(2,5-dihydroxyfenil)-(3-piridin-
2-il)-propenon in the inhibition of colon cancer 
cell WiDr growth. The paramereter used in this 
research is the inhibition concentration 50% 
(IC50). The lower the IC50 value, the tested 
compound is more potent in the inhibition of 
cancer cell growth. The result of cytotoxic 
assay showed that 1-(2,5-dihydroxyfenil)-(3-
piridin-2-il)-propenon in the concentration of 1-
100 µM has the cytotoxic activity towards 
WiDr cell in dose dependent manner. The 
higher the concentration of 1-(2,5-
dihydroxyfenil)-(3-piridin-2-il)-propenon 
given, the lower the percent of cell viability 
(Fig. 1). 
Based on the calculation by the linier 
regretion log concentration versus % cell 
viability showed that -(2,5-dihydroxyfenil)-(3-
piridin-2-il)-propenon gives IC50 values 16 µM 
on WiDr cell. This result showed that the tested 
compound has the better sensitivity and 
selectivity towards Colon cancer cell WiDr, 
than towards 5-fluorouracil (5-FU) with IC50 
496 µM (Ikawati, 2008). The observation of 
cell morfology after the treatment with tested 
compound showed the number of death cells 
were increasing as the concentration of 1-(2,5-
dihidroksifenil)-(3-piridin-2-il)-propenon were 
increased.
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Figure 1. The cytotoxic effect of 1-(2,5-dihydroxyphenyl)-3-pyridine-2-yl-propenone on WiDr cells. 
The cells were treated with 1-(2,5-dihydroxyphenyl)-3-pyridine-2-yl-propenone in the concentration of 
1-100 µM and then incubated for 24 h. After 24 hours, cells were added by MTT reagent to calculate 
the absorbance which represent viable cells. (A) Diagram of WiDr cells viability after 24 hours 1-(2,5-
dihydroxyphenyl)-3-pyridine-2-yl-propenone treatment. WiDr  cells morphology of (B) cell control; (C) 
after 24 hours 10 µM; (D) 50 µM 1-(2,5-dihydroxyphenyl)-3-pyridine-2-yl-propenone treatment. 
Observation was done by using converted microscope with 400 x magnification. Cell viability profile was 
shown from average ± standard of error (SE) of 3 experiments. The normal cells are showed by the 
bold arrow (          ) and the changed morphology cells are showed by the thin Arrow (           ). 
  
 
CONCLUSION 
 
Compound 1-(2,5-dihydroxyphenyl)-3-
pyridine-2-yl-propenone has the cytotoxic 
activity in the inhibition of colon cancer cell 
WiDr with IC50 value 16 µM. 
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